OpenEvidence says nearly two-thirds of ~1M US physicians use its AI search engine; a source says it is on track to generate $400M-$500M in 2026 ad revenue

Physician search tools now offer advertising revenue that rivals established consumer platforms.

OpenEvidence, an AI-powered search engine for physicians, reports that nearly two-thirds of approximately one million U.S. physicians are now users of its platform. The company's founder stated this adoption rate, which has sparked discussions regarding patient care, indicates significant penetration within the medical community. A separate industry source projects that OpenEvidence is on track to generate between $400 million and $500 million in advertising revenue by 2026. This financial projection highlights the growing economic potential of AI-driven tools targeting professional, high-value markets.

The widespread adoption of OpenEvidence by U.S. physicians suggests a strong market appetite for AI-assisted clinical information retrieval. This trend indicates a potential shift in how medical professionals access and process data, moving away from traditional search methods towards integrated, specialized AI solutions. The success of an ad-supported model also signals that healthcare professionals are receptive to commercial content if it is effectively integrated into their workflow, opening new avenues for advertising within the medical technology sector.

The projected $400M-$500M in ad revenue by 2026 positions OpenEvidence as a significant player not just in AI tools, but in digital advertising. This forecast implies that specialized AI platforms can monetize their user base effectively, potentially influencing other niche markets to pursue similar advertising-driven strategies. Competitors and advertisers alike will be watching closely to see if this model scales and what it means for the cost and availability of specialized AI services in healthcare and beyond.